ASX:LTR drops as Liontown slides on lithium ahead of June numbers

ASX:LTR drops as Liontown slides on lithium ahead of June numbers

June 29, 2026

SYDNEY, June 30, 2026, 07:04 AEST

  • ASX cash shares sat in pre-open with regular trading set for 09:59:45 Sydney.
  • Liontown traded at A$1.66, falling 16.16% from A$1.98 across the last seven sessions.
  • Monday’s rights activity was light against the overall equity base, with 2.017 million rights lapsing and 146,958 new FY26 long-term performance rights issued.

Liontown Limited heads into Tuesday’s ASX pre-open at A$1.66, with the stock under pressure from a week-long selloff that bucked a stronger local market. The S&P/ASX 200 index (INDEXASX:XJO) finished Monday up 0.7% at 8,823. Liontown’s own site last showed shares at A$1.66 early Tuesday. Normal matching on ASX is set for 09:59:45 Sydney time.

The key number is the gap between Liontown’s share move and its operating numbers. Liontown shares have fallen 16.16% from A$1.98, but the stock is still up 137.14% for FY2026 and 5.73% in 2026 so far. China lithium carbonate, which is used as a rough proxy but isn’t Liontown’s spodumene, dropped 15.22% over the last month to 151,750 yuan a tonne as of June 29.

MarkerLatest readInvestor read-through
Liontown latest priceA$1.66trading near late-June levels again
Fall from A$1.98-16.16%rough de-rating over the past week
Fall from 2026 high of A$2.65-37.4%can’t reclaim the May high
FY2026 move+137.14%rerate still holding up big for the year
China lithium carbonate proxy, one month-15.22%lithium prices backing off

At A$1.66 per share, Liontown’s 3,179,110,946 shares put its value at about A$5.28 billion. New securities filings out Monday didn’t move that figure much. The company reported that 2.017 million employee and performance rights lapsed, about 0.063% of its ordinary shares. It issued another 146,958 FY26 long-term performance rights, or roughly 0.0046%.

Monday capital itemSecuritiesScale versus ordinary shares
Expired employee and performance rights2,016,7830.063%
New performance rights for FY26 LTI146,9580.0046%
Listed ordinary shares3,179,110,946base capital

The stock now looks pinned more to lithium prices and what happens in the June quarter, not Monday’s rights paperwork. Liontown’s next update is set for July 28, then it’s the FY26 results on Aug. 31, per the investor calendar.

Liontown’s last results looked better operationally than the recent stock move suggests. The company posted A$55 million operating cash flow, A$33 million positive net cash flow, and finished the quarter with A$424 million cash. Liontown sold 83,912 dmt of spodumene concentrate at an average realised price of US$1,845/dmt SC6e for the March quarter. “Liontown is generating positive net cash flow,” Managing Director and CEO Tony Ottaviano said, adding the company is “on track to meet the FY2026 guidance.”

March quarter metricQ3 FY2026Q2 FY2026Change
Concentrate output96,367 dmt105,342 dmt-9%
Concentrate sales83,912 dmt112,122 dmt-25%
Avg realised priceUS$1,845/dmt SC6eUS$985/dmt SC6e+87%
Total revenueA$197 millionA$130 million+51%
Cash balanceA$424 millionA$390 million+9%
AISCA$1,251/dmt soldA$1,059/dmt sold+18%

Revenue climbed as realised prices nearly doubled from the December quarter, offsetting weaker sales volumes. The focus now shifts to June-quarter realised prices, recovery rate, and sales tonnage, which look more important for the next move in the shares than Monday’s small rights notices.

The expansion case brings another test. Liontown said April 29 that early works and long-lead procurement for the Kathleen Valley expansion are underway before a final investment decision, which is expected by end of Q1 FY2027. The company expects to spend about A$12 million on a ball mill over the next year, with another A$15 million to A$18 million going to early works in FY2026. Liontown flagged total pre-FID cash outlay could reach up to A$77 million. That’s about 18% of its cash at March end.

Lithium names aren’t just trading lower. Reuters last week quoted Fastmarkets CEO Raju Daswani saying, “The period of market overcorrection is over,” and added that “Energy storage has become a primary driver of growth.” Albemarle Corp exec Eric Norris said to Reuters: “Grid storage is much more evenly distributed around the world.” Reuters

Rio Tinto Group is making a push into lithium. Jérôme Pécresse, who runs its aluminium and lithium unit, told Reuters the company is aiming for 200,000 tonnes of lithium capacity by 2028, and said Rio wants to “build on time and on budget.” But he also described lithium as “a market that is trying to find itself.” Reuters

Artur Ślesik

Artur Ślesik is a technology and financial markets journalist at Bez-kabli.pl, covering artificial intelligence, semiconductors, technology stocks and emerging innovations. A graduate of Warsaw University of Technology, he combines a technical background with market analysis to explain how new technologies are shaping industries, businesses and investment trends worldwide.

Stock Market Today

  • Cochlear Slides Toward 2016 Levels After Slashing FY26 Profit Guidance, Market Value Drops A$11.7 Billion
    June 29, 2026, 5:49 PM EDT. Cochlear Limited (ASX:COH) shares ended at A$121.08, off almost 60% from their FY25 high of A$300.42, erasing about A$11.7 billion in market value. The hearing-implant maker cut its FY26 profit forecast to A$290 million-A$330 million, which is 31% below its earlier estimate, as sales struggled in developed markets, margin pressure mounted, risks grew in Middle East receivables, and the Australian dollar strengthened. While the healthcare sector advanced, Cochlear missed out, dropping more than 54% so far this year. The company also pointed to possible A$10 million in Middle East receivables losses and A$25 million in foreign exchange costs. Market cap sits around A$7.9 billion, similar to ten years ago even as new products and higher sales were reported. A much lower guidance and outside headwinds continue to hit the share price.